search

Scientists at the Luxembourg Centre for Systems Biomedicine (LCSB) have succeeded in turning human stem cells from skin samples into “tiny, three-dimensional, brain-like cultures”. 

The LCSB, part of the University of Luxembourg, said the cultures behaved “very similarly” to cells in the human midbrain.

They said they had succeeded in getting various cell types to develop, connect, exchange signals and “produce metabolic products typical of the active brain”.

Professor Jens Schwamborn, in whose research group the work was done, said: “Our cell cultures open new doors to brain research. “We can now use them to study the causes of Parkinson’s disease and how it could possibly be effectively treated.”

The human “midbrain” – particularly the structure known as the substantia nigra – is of great interest in the fight against Parkinson’s. Researchers are unable to remove cells from this region of the brain for study due to ethical concerns. But the work done at the LCSB may help researchers to resolve this problem.

 

Read more

10 key technologies shaping the post COVID-19 economy

16-09-2020

The COVID-19 pandemic has changed our ways of living, working, consuming and travelling, and has had a huge impact on companies’ and consumers’ use of technology. Luxinnovation lists 10 key technologies that will play a crucial role in the economy over the months and years to come.
Read more

Eureka Calls 2020

06-05-2020

Luxembourg is participating this year in three Eureka calls for projects as a funding country, in the fields of advanced materials, healthy ageing and AI.
Read more

Public-private research partnerships to combat COVID-19

29-04-2020

Shortly after the outbreak of the pandemic, the Luxembourg National Research Fund (FNR) launched a call for research projects addressing the current and future challenges of COVID-19. The call is now open to public-private partnerships, thus making it possible for Luxembourg-based enterprises and research organisations to join forces in order to combat the disease.
Read more

From spin-off to technology platform: the MPG story

22-04-2020

Take a completely unique molecular plasma technology and combine it with a visionary team. Place them in a nurturing national ecosystem, and you have the main ingredients of the success story of Molecular Plasma Group. The Luxembourg start-up is about to make a major international breakthrough.
Read more

Luxembourg start-up Doctena offers remote medical consultation solution

06-04-2020

In view of the urgent need to restrict face-to-face meetings as much as possible due to the COVID-19 pandemic, the Luxembourg government is allowing remote medical consultations during the time of the crisis. Reacting quickly, Luxembourg start-up Doctena has added a video conference module to its leading online platform for booking medical appointments.
Read more

All news

Close